SDRIFE and bullous reaction after treatment with enfortumab vedotin plus pembrolizumab: Case series
Por:
Lluch-Galcerá, JJ, Manzanares-Oliver, N, Martinez-Molina, M, Valdivieso, L, Boada, A, Segura, S, Rovira, R, Pujol, RM and Jaka, A
Publicada:
1 ago 2024
Ahead of Print:
1 may 2024
Resumen:
Filiaciones:
Lluch-Galcerá, JJ:
Univ Autonoma Barcelona, Hosp Univ Germans Trials & Pujol, Inst Invest Germans Trias & Pujol, Dept Med,Dept Dermatol, Badalona, Barcelona, Spain
Manzanares-Oliver, N:
Univ Autonoma Barcelona UAB, Hosp Mar, Inst Mar Invest Med, Dept Dermatol, Barcelona, Spain
Univ Pompeu Fabra UPF, Barcelona, Spain
Martinez-Molina, M:
Univ Autonoma Barcelona, Hosp Univ Germans Trials & Pujol, Inst Invest Germans Trias & Pujol, Dept Med,Dept Dermatol, Badalona, Barcelona, Spain
:
Hosp Badalona Germans Trias & Pujol, Dept Pathol, Badalona, Barcelona, Spain
:
Univ Autonoma Barcelona, Hosp Univ Germans Trials & Pujol, Inst Invest Germans Trias & Pujol, Dept Med,Dept Dermatol, Badalona, Barcelona, Spain
Segura, S:
Univ Autonoma Barcelona UAB, Hosp Mar, Inst Mar Invest Med, Dept Dermatol, Barcelona, Spain
Univ Pompeu Fabra UPF, Barcelona, Spain
Rovira, R:
Univ Autonoma Barcelona UAB, Hosp Mar, Inst Mar Invest Med, Dept Dermatol, Barcelona, Spain
Univ Pompeu Fabra UPF, Barcelona, Spain
Pujol, RM:
Univ Autonoma Barcelona UAB, Hosp Mar, Inst Mar Invest Med, Dept Dermatol, Barcelona, Spain
Univ Pompeu Fabra UPF, Barcelona, Spain
:
Univ Autonoma Barcelona, Hosp Univ Germans Trials & Pujol, Inst Invest Germans Trias & Pujol, Dept Med,Dept Dermatol, Badalona, Barcelona, Spain
Hosp Badalona Germans Trias & Pujol, Dept Dermatol, C-Carretera Canyet,S-N, Badalona 08916, Barcelona, Spain
Bronze
|